Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | We are pioneering personalized treatment for AMD using |
Description | Genetic research reveals that zinc supplement formulations used to prevent the progression of AMD are not safe for 15% of patients. Learn |
Keywords | N/A |
WebSite | arcticdx.com |
Host IP | 66.96.160.195 |
Location | United States |
Site | Rank |
US$3,569,005
Last updated: 2023-05-14 22:51:19
arcticdx.com has Semrush global rank of 2,965,618. arcticdx.com has an estimated worth of US$ 3,569,005, based on its estimated Ads revenue. arcticdx.com receives approximately 411,809 unique visitors each day. Its web server is located in United States, with IP address 66.96.160.195. According to SiteAdvisor, arcticdx.com is safe to visit. |
Purchase/Sale Value | US$3,569,005 |
Daily Ads Revenue | US$3,295 |
Monthly Ads Revenue | US$98,834 |
Yearly Ads Revenue | US$1,186,008 |
Daily Unique Visitors | 27,454 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
arcticdx.com. | A | 3599 | IP: 66.96.160.195 |
arcticdx.com. | NS | 3600 | NS Record: ns2.netfirms.com. |
arcticdx.com. | NS | 3600 | NS Record: ns1.netfirms.com. |
arcticdx.com. | MX | 3600 | MX Record: 1 arcticdx-com.mail.protection.outlook.com. |
arcticdx.com. | MX | 3600 | MX Record: 30 mx.arcticdx.com. |
arcticdx.com. | TXT | 3600 | TXT Record: v=spf1 ip4:66.96.128.0/18 ?all |
arcticdx.com. | TXT | 3600 | TXT Record: v=spf1 include:_spf.google.com include:spf.protection.outlook.com ~all |
COVID-19 Testing For Eye Care Professionals For Eye Care Professionals Product Science In-Office Testing Order Now Order Kit About Arctic About Arctic Our Team Our Products In the News Privacy Policy Patents and Trademarks Contact Us Genetics and Supplements Genetics and Supplements AREDS and Genetics Avoiding Harm Zinc and AMD AMD Progression Getting Tested Find a Doctor Select Page We Are Pioneering Personalized Treatment for AMD Using Genetics Genetic research reveals that zinc-based eye vitamins like AREDS/AREDS2 used to prevent the progression of age-related macular degeneration (AMD) are not safe for 15% of patients . For AMD patients with a specific genotype, the risk of developing wet AMD is tripled by taking supplemental zinc formulations (25 mg per day and higher), which increases the risk of vision loss. Learn more about the research Eye care professionals who understand the risk of AMD progression can ensure their patients get the right treatment. Genetic testing for |
HTTP/1.1 200 OK Date: Fri, 24 Dec 2021 03:55:40 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 123749 Connection: keep-alive Server: Apache/2 Last-Modified: Fri, 24 Dec 2021 03:45:41 GMT ETag: "1e365-5d3dc305d595e" Accept-Ranges: bytes Vary: Accept-Encoding,Cookie Cache-Control: max-age=3600 Expires: Fri, 24 Dec 2021 04:55:40 GMT Referrer-Policy: no-referrer-when-downgrade X-Powered-By: W3 Total Cache/0.9.3 Age: 0 |
Domain Name: ARCTICDX.COM Registry Domain ID: 231105171_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domain.com Registrar URL: http://www.domain.com Updated Date: 2021-09-30T11:34:04Z Creation Date: 2005-10-15T16:41:10Z Registry Expiry Date: 2022-10-15T16:41:10Z Registrar: Domain.com, LLC Registrar IANA ID: 886 Registrar Abuse Contact Email: compliance@domain-inc.net Registrar Abuse Contact Phone: 602-226-2389 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.NETFIRMS.COM Name Server: NS2.NETFIRMS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-27T07:01:37Z <<< |